NCT03961035View on ClinicalTrials.gov

Comparative Effectiveness and Tolerance of Subliminal Subthreshold Transscleral Cyclophotocoagulation

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

January 12, 2019

Conditions
Glaucoma
Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03961035 - Comparative Effectiveness and Tolerance of Subliminal Subthreshold Transscleral Cyclophotocoagulation | Biotech Hunter | Biotech Hunter